Allarity Therapeutics Inc

NASDAQ:ALLR  
1.77
+0.01 (+0.57%)
Earnings Announcements

Allarity Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/27/2022 21:50 GMT
Allarity Therapeutics Inc (ALLR) - Allarity Therapeutics Reports First Quarter 2022 Financial Results.
Allarity Therapeutics Inc - Qtrly Loss per Share $0.56.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.